142 related articles for article (PubMed ID: 24416998)
1. The class I HDAC inhibitor Romidepsin targets inflammatory breast cancer tumor emboli and synergizes with paclitaxel to inhibit metastasis.
Robertson FM; Chu K; Boley KM; Ye Z; Liu H; Wright MC; Moraes R; Zhang X; Green TL; Barsky SH; Heise C; Cristofanilli M
J Exp Ther Oncol; 2013; 10(3):219-33. PubMed ID: 24416998
[TBL] [Abstract][Full Text] [Related]
2. Modeling and characterization of inflammatory breast cancer emboli grown in vitro.
Lehman HL; Dashner EJ; Lucey M; Vermeulen P; Dirix L; Van Laere S; van Golen KL
Int J Cancer; 2013 May; 132(10):2283-94. PubMed ID: 23129218
[TBL] [Abstract][Full Text] [Related]
3. The effects of CEP-37440, an inhibitor of focal adhesion kinase, in vitro and in vivo on inflammatory breast cancer cells.
Salem I; Alsalahi M; Chervoneva I; Aburto LD; Addya S; Ott GR; Ruggeri BA; Cristofanilli M; Fernandez SV
Breast Cancer Res; 2016 Mar; 18(1):37. PubMed ID: 27009091
[TBL] [Abstract][Full Text] [Related]
4. Inflammatory breast cancer tumor emboli express high levels of anti-apoptotic proteins: use of a quantitative high content and high-throughput 3D IBC spheroid assay to identify targeting strategies.
Arora J; Sauer SJ; Tarpley M; Vermeulen P; Rypens C; Van Laere S; Williams KP; Devi GR; Dewhirst MW
Oncotarget; 2017 Apr; 8(16):25848-25863. PubMed ID: 28460441
[TBL] [Abstract][Full Text] [Related]
5. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
6. Cooperative role of E-cadherin and sialyl-Lewis X/A-deficient MUC1 in the passive dissemination of tumor emboli in inflammatory breast carcinoma.
Alpaugh ML; Tomlinson JS; Kasraeian S; Barsky SH
Oncogene; 2002 May; 21(22):3631-43. PubMed ID: 12032865
[TBL] [Abstract][Full Text] [Related]
7. Romidepsin: a novel histone deacetylase inhibitor for cancer.
Bertino EM; Otterson GA
Expert Opin Investig Drugs; 2011 Aug; 20(8):1151-8. PubMed ID: 21699444
[TBL] [Abstract][Full Text] [Related]
8. Molecular and pharmacological blockade of the EP4 receptor selectively inhibits both proliferation and invasion of human inflammatory breast cancer cells.
Robertson FM; Simeone AM; Mazumdar A; Shah AH; McMurray JS; Ghosh S; Cristofanilli M
J Exp Ther Oncol; 2008; 7(4):299-312. PubMed ID: 19227010
[TBL] [Abstract][Full Text] [Related]
9. Romidepsin (depsipeptide) induced cell cycle arrest, apoptosis and histone hyperacetylation in lung carcinoma cells (A549) are associated with increase in p21 and hypophosphorylated retinoblastoma proteins expression.
Vinodhkumar R; Song YS; Devaki T
Biomed Pharmacother; 2008 Feb; 62(2):85-93. PubMed ID: 17644301
[TBL] [Abstract][Full Text] [Related]
10. Suberoylanilide hydroxamic acid blocks self-renewal and homotypic aggregation of inflammatory breast cancer spheroids.
Robertson FM; Woodward WA; Pickei R; Ye Z; Bornmann W; Pal A; Peng Z; Hall CS; Cristofanilli M
Cancer; 2010 Jun; 116(11 Suppl):2760-7. PubMed ID: 20503408
[TBL] [Abstract][Full Text] [Related]
11. Smac mimetic Birinapant induces apoptosis and enhances TRAIL potency in inflammatory breast cancer cells in an IAP-dependent and TNF-α-independent mechanism.
Allensworth JL; Sauer SJ; Lyerly HK; Morse MA; Devi GR
Breast Cancer Res Treat; 2013 Jan; 137(2):359-71. PubMed ID: 23225169
[TBL] [Abstract][Full Text] [Related]
12. Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma.
Paoluzzi L; Scotto L; Marchi E; Zain J; Seshan VE; O'Connor OA
Clin Cancer Res; 2010 Jan; 16(2):554-65. PubMed ID: 20068080
[TBL] [Abstract][Full Text] [Related]
13. An intact overexpressed E-cadherin/alpha,beta-catenin axis characterizes the lymphovascular emboli of inflammatory breast carcinoma.
Tomlinson JS; Alpaugh ML; Barsky SH
Cancer Res; 2001 Jul; 61(13):5231-41. PubMed ID: 11431364
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological targeting of GLI1 inhibits proliferation, tumor emboli formation and in vivo tumor growth of inflammatory breast cancer cells.
Oladapo HO; Tarpley M; Sauer SJ; Addo KA; Ingram SM; Strepay D; Ehe BK; Chdid L; Trinkler M; Roques JR; Darr DB; Fleming JM; Devi GR; Williams KP
Cancer Lett; 2017 Dec; 411():136-149. PubMed ID: 28965853
[TBL] [Abstract][Full Text] [Related]
15. Phase II trial of the histone deacetylase inhibitor romidepsin in patients with recurrent/metastatic head and neck cancer.
Haigentz M; Kim M; Sarta C; Lin J; Keresztes RS; Culliney B; Gaba AG; Smith RV; Shapiro GI; Chirieac LR; Mariadason JM; Belbin TJ; Greally JM; Wright JJ; Haddad RI
Oral Oncol; 2012 Dec; 48(12):1281-8. PubMed ID: 22748449
[TBL] [Abstract][Full Text] [Related]
16. E-cadherin accumulation within the lymphovascular embolus of inflammatory breast cancer is due to altered trafficking.
Ye Y; Tellez JD; Durazo M; Belcher M; Yearsley K; Barsky SH
Anticancer Res; 2010 Oct; 30(10):3903-10. PubMed ID: 21036701
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells mediate the clinical phenotype of inflammatory breast cancer in a preclinical model.
Lacerda L; Debeb BG; Smith D; Larson R; Solley T; Xu W; Krishnamurthy S; Gong Y; Levy LB; Buchholz T; Ueno NT; Klopp A; Woodward WA
Breast Cancer Res; 2015 Mar; 17(1):42. PubMed ID: 25887413
[TBL] [Abstract][Full Text] [Related]
18. Clinically relevant inflammatory breast cancer patient-derived xenograft-derived ex vivo model for evaluation of tumor-specific therapies.
Eckhardt BL; Gagliardi M; Iles L; Evans K; Ivan C; Liu X; Liu CG; Souza G; Rao A; Meric-Bernstam F; Ueno NT; Bartholomeusz GA
PLoS One; 2018; 13(5):e0195932. PubMed ID: 29768500
[TBL] [Abstract][Full Text] [Related]
19. Characterization and Targeting of Platelet-Derived Growth Factor Receptor alpha (PDGFRA) in Inflammatory Breast Cancer (IBC).
Joglekar-Javadekar M; Van Laere S; Bourne M; Moalwi M; Finetti P; Vermeulen PB; Birnbaum D; Dirix LY; Ueno N; Carter M; Rains J; Ramachandran A; Bertucci F; van Golen KL
Neoplasia; 2017 Jul; 19(7):564-573. PubMed ID: 28609680
[TBL] [Abstract][Full Text] [Related]
20. Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice.
Aggarwal BB; Shishodia S; Takada Y; Banerjee S; Newman RA; Bueso-Ramos CE; Price JE
Clin Cancer Res; 2005 Oct; 11(20):7490-8. PubMed ID: 16243823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
